What is Leqembi? The first Alzheimer’s treatment approved today in Saudi Arabia | World News
Leqembi targets beta-amyloid plaques in the brain, aiming to slow Alzheimer’s progression in patients with mild cognitive impairment The Saudi Food and Drug Authority (SFDA) announced today the official approval of Leqembi, the first Alzheimer’s treatment available in Saudi Arabia. This approval marks a significant milestone in addressing Alzheimer’s, a progressive brain disorder that affects […]